Crossref Citations

1. Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?
Sabira Tahseen, Armand Van Deun, Bouke C de Jong, Tom Decroo
Journal of Antimicrobial Chemotherapy  year: 2020  
doi: 10.1093/jac/dkaa489